Sabra Healthcare REIT (NASDAQ:SBRA) Announces Quarterly Earnings Results

Sabra Healthcare REIT (NASDAQ:SBRA) released its quarterly earnings results on Monday. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.27), FiscalAI reports. The firm had revenue of $230.11 million during the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.

Sabra Healthcare REIT Stock Performance

Shares of Sabra Healthcare REIT stock traded down $0.56 on Monday, reaching $20.61. 4,340,697 shares of the stock were exchanged, compared to its average volume of 2,774,260. The business has a 50 day moving average price of $19.77 and a two-hundred day moving average price of $19.92. The firm has a market capitalization of $5.20 billion, a price-to-earnings ratio of 32.71, a PEG ratio of 1.64 and a beta of 0.64. Sabra Healthcare REIT has a twelve month low of $17.17 and a twelve month high of $22.77. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96.

Wall Street Analysts Forecast Growth

SBRA has been the subject of several analyst reports. Truist Financial increased their price objective on Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. UBS Group set a $25.00 target price on Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Barclays started coverage on Sabra Healthcare REIT in a research report on Tuesday, July 7th. They set an “overweight” rating and a $21.00 target price on the stock. Raymond James Financial began coverage on Sabra Healthcare REIT in a research note on Wednesday, June 17th. They issued an “underperform” rating for the company. Finally, Wells Fargo & Company raised their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Eight equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Sabra Healthcare REIT currently has a consensus rating of “Moderate Buy” and a consensus target price of $22.25.

Hedge Funds Weigh In On Sabra Healthcare REIT

Several hedge funds and other institutional investors have recently bought and sold shares of SBRA. Larson Financial Group LLC raised its position in Sabra Healthcare REIT by 42.3% during the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 553 shares during the last quarter. Inspire Investing LLC boosted its holdings in shares of Sabra Healthcare REIT by 2.3% in the 4th quarter. Inspire Investing LLC now owns 24,747 shares of the real estate investment trust’s stock valued at $469,000 after acquiring an additional 565 shares during the last quarter. Natixis Advisors LLC increased its stake in shares of Sabra Healthcare REIT by 2.2% in the third quarter. Natixis Advisors LLC now owns 27,664 shares of the real estate investment trust’s stock worth $516,000 after acquiring an additional 598 shares during the period. UMB Bank n.a. raised its holdings in shares of Sabra Healthcare REIT by 28.3% during the fourth quarter. UMB Bank n.a. now owns 3,065 shares of the real estate investment trust’s stock worth $58,000 after purchasing an additional 676 shares during the last quarter. Finally, Smartleaf Asset Management LLC raised its holdings in shares of Sabra Healthcare REIT by 97.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 714 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.